No takes yet. Share an insight, caveat, or question.
Case-control study demonstrates increased hypoglycemic therapy initiation in oral glucocorticoid users, indicating strong dose-dependent hyperglycemia risk.
Jerry H. Gurwitz (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: